index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral

Open Access

53 %

Mots clés

Data integration Anti-IgE IgG Auto-immunité Anti-interleukin-6 Aged Cytokines Biopsy IBM Antibody responses Skeletal muscle Anticorps spécifique des myosites Dependovirus/genetics/immunology AAV vectors AAV antibody Adeno-associated vector Assisted communication devices Acute Kidney Injury/epidemiology/etiology Myositis and muscle disease Lysosomal storage diseases Dermatomyositis Anti-agalsidase antibodies Amyotrophy Cancer Analyses multidimensionnelles COVID-19 Adeno-associated virus vector Antibodies Myocarditis Mass cytometry Arthritis Immune checkpoint inhibitors B cell homeostasis Multidisciplinarity CD8+ T-bet+ cells Aldostérone Antisynthetase syndrome Anti‐mitochondrial antibodies Acid-alpha-glucosidase Antiphospholipid syndrome Anticorps anti-agalsidase Adult Auto-antibodies Case reports Interstitial lung disease Gene therapy Adverse drug reactions Adeno-associated virus Adolescence Fabry disease Immunotherapy Interferon CD8+T cells AAV Amyotrophic lateral sclerosis Autoantibodies DM Humans Anti-MDA5 autoantibodies Antisynthetase B-lymphocyte Antisynthétase Deep immune profiling Muscle Biomarqueurs Idiopathic inflammatory myopathies Anémie hémolytique Agalsidase Male Biomarker AAV humoral immunity Abnormal movement Anti-drug antibodies Female Machine learning Biomarkers Polymyositis Middle Aged AAV vector Active Adjudication IMNM Myopathy Animals Inflammatory myopathy Systems biology Prognosis Anti-Mi2 Bioelectrical impedance analysis Inborn errors of metabolism Inclusion body myositis Outcome measures Anti-synthetase syndrome Myositis Sphingosine-1-phosphate Autoantibody Auto‐antibodies Aldosterone Inflammation Autoimmune diseases Autoimmunity